logo
Federal judge denies Perdue Farm's request to drop lawsuit alleging PFAS contamination in Maryland

Federal judge denies Perdue Farm's request to drop lawsuit alleging PFAS contamination in Maryland

CBS News7 days ago
A federal judge in Maryland denied Perdue Farm's request Wednesday to dismiss a lawsuit that alleges the company contaminated a community with PFAS, or forever chemicals.
The lawsuit, filed in early August on behalf of five Salisbury residents, claims that the agribusiness giant dumped wastewater that contained PFAS (per- and polyfluoroalkyl substances) into the ground near its facility.
In response, Perdue denied any wrongdoing and said it believes the lawsuit is more about the law firm's financial gain rather than the alleged contamination.
"Perdue AgriBusiness remains focused on transparency, accountability, and identifying the true source of contamination, since PFAS is not part of our manufacturing process," the company said in a previous statement.
On Wednesday, U.S. District Judge Stephanie Gallagher denied the company's request to throw out the lawsuit. However, she did throw out two of the seven charges, including one that called for the company to stop its alleged dumping and pay for environmental cleanup measures.
"We welcome the Court's decision to dismiss parts of the plaintiffs' case, including unsubstantiated claims attempting to link alleged health conditions to our operations," the company said in a statement. "We're confident the facts will speak for themselves as the case moves forward."
According to the lawsuit, filed by the Brockstedt Mandalas Federico law firm, the Maryland Department of the Environment (MDE) discovered in September 2023 that Perdue's wastewater contained high levels of PFAS chemicals. The water was being disposed of on cropland and forest near Peggy's Branch stream.
Nearly 500 homes within two miles of Perdue's wastewater disposal field use private wells for potable water, according to the lawsuit.
The lawsuit also claims that Perdue had not tested for those specific substances but began testing for them around September 2023.
In the lawsuit, the Salisbury residents claim that the company waited until October 2024 to notify neighbors about the PFAS chemicals.
A spokesperson for Perdue told WJZ that it had already taken steps to address the high PFAS levels before the lawsuit was filed, including testing well water at 673 properties, installing PFAS treatment systems at impacted sites and removing potential sources of PFAS from its facility.
"In late 2023, a state-wide sampling effort revealed elevated concentrations of PFAS at the facility and MDE requested additional testing to determine the nature, source and extent of any PFAS," Perdue said in a statement. "In September 2024, MDE notified us that further testing, remediation and public notification would be required. We immediately began identifying the impacted area and, following MDE's guidance, swiftly notified the community in late September and early October 2024."
The residents named in the lawsuit claim they "suffered, and continue to suffer, from a variety of health effects that are known to be caused by exposure" to PFAS chemicals.
"Today's ruling marks an important milestone in this community's effort to obtain accountability and justice regarding Perdue's extensive PFAS pollution of the area's groundwater," a spokesperson for the law firm said in a statement. "Perdue has known about this public health crisis for nearly two years and concealed it until the community came together and filed this lawsuit. Unfortunately, Perdue is failing to meaningfully address the contamination while it continues production for its own profit."
Judge Gallager said the case will proceed as MDE continues its investigation.
Perdue has continued to deny any wrongdoing and said it is cooperating with state regulators.
"Perdue AgriBusiness has worked closely and openly with the Maryland Department of the Environment—the only agency empowered to oversee remediation and assess impacts," the company said.
"Our commitment to our neighbors remains unchanged," the company said Wednesday. "We are continuing to work closely with the Maryland Department of the Environment (MDE) on a comprehensive response plan, which is already well underway."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Bigbear.ai: BBAI Stock To $1?
Bigbear.ai: BBAI Stock To $1?

Forbes

timea minute ago

  • Forbes

Bigbear.ai: BBAI Stock To $1?

(NYSE:BBAI), an AI solutions provider focused on national security, carries material downside risks that deserve close attention. Trading at 8x trailing revenue—nearly three times its four-year average of 3x—the stock appears highly exposed to market corrections. Historical precedent shows BBAI can drop 95% during periods of broader market stress, and multiple fundamental and technical factors point to further downside risk. We detail these risks below. If you prefer pursuing upside with less volatility than a single-stock position, consider the High Quality Portfolio. It has comfortably outperformed its benchmark—a blend of the S&P 500, Russell, and S&P MidCap indexes—and has delivered returns exceeding 91% since inception. Also see – SoundHound AI: SOUN Stock To $2? Historical Volatility Pattern BBAI's history shows extreme sensitivity to market drawdowns. The stock fell 95.0% from $12.69 (April 13, 2022) to $0.63 (December 29, 2022), while the S&P 500 declined just 25.4% over the inflation-driven selloff. The shares still haven't returned to prior highs, indicating structural fragility beyond normal cycles. Recent moves echo this pattern. A 6% drop on August 19, 2025, amid profit-taking in high-growth names underscores BBAI's hypersensitivity. A repeat 95% drawdown from the February 2024 high of $10 would put the stock below $1—a scenario with clear historical precedent. Valuation Vulnerability Fundamental Growth Impediments Government Dependency Concentration: Heavy reliance on federal contracts introduces several risks: Execution Capability Questions: Persistent revenue stagnation despite wins suggests operational hurdles: Market Saturation Risk: The defense AI market, while expanding, faces constraints: Broader macro risks compound these issues. As a loss-making company, BBAI is particularly sensitive to high interest rates, which typically pressure valuations for unprofitable firms. While geopolitical tensions currently support defense budgets, that tailwind is cyclical; normalization could weigh on AI defense funding. In risk-off markets, speculative names are often sold first, exposing BBAI to outsized downside. See – Buy or Fear BBAI Stock – for more. Of Course Not Everything Is Murky A sizable $380 million backlog provides visibility into future revenue. A $391 million cash balance offers an operating runway that reduces near-term liquidity risk. Continued geopolitical tensions could sustain or increase defense AI spending, benefiting The company also has room for operational improvements under new leadership—Kevin McAleenan as CEO and Sean Ricker as CFO—which could support efficiency and profitability. One of our earlier pieces on covered the positive catalysts at work. The Verdict For risk-averse investors, BBAI's downside risks currently outweigh the potential reward. Stretched valuation, execution challenges, extreme volatility, and a history of severe drawdowns argue for caution. Investors should be prepared for possible 60–90% declines during market stress, with sub-$1 levels representing a historically supported worst-case. The stock's failure to reclaim prior highs despite favorable markets hints at structural issues not yet fully reflected in valuation. Given today's risk-reward, waiting for materially lower entry points—or avoiding the name in conservative portfolios—appears prudent. Now, we apply a risk assessment framework while constructing the Trefis High Quality (HQ) Portfolio,which, with a collection of 30 stocks, has a track record of comfortably outperforming the S&P 500 over the last 4-year period. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride as evident in HQ Portfolio performance metrics.

Estée Lauder Stock Falls as Quarterly Losses and Outlook Miss Expectations
Estée Lauder Stock Falls as Quarterly Losses and Outlook Miss Expectations

Yahoo

time29 minutes ago

  • Yahoo

Estée Lauder Stock Falls as Quarterly Losses and Outlook Miss Expectations

KEY TAKEAWAYS Estée Lauder shares are down in premarket trading Wednesday after the cosmetics company posted a wider-than-forecast quarterly loss and a disappointing outlook for the upcoming year. The New York-based company, whose brands include MAC, La Mer, and Jo Malone, said Chinese consumer demand remained "subdued." The company's shares are falling 6% in premarket trading but have gained 19% so far this year entering Wednesday. Estée Lauder (EL) shares are down 6% in premarket trading Wednesday after the cosmetics company posted a wider-than-forecast quarterly loss and a disappointing outlook for the upcoming year. The New York-based company, whose brands include MAC, La Mer, and Jo Malone, posted a fourth-quarter loss per share of $1.51, wider than the $0.79 loss per share it reported the same period last year. Its net sales for the three months to June 30 was $3.42 billion, down 12% year-over-year, dragged lower by declines in the sale of skin care products from its own brand and La Mer in the Asian travel market. The company said that Chinese consumer demand remained "subdued." Analysts polled by Visible Alpha had projected a $0.07 fourth-quarter loss per share and $3.41 billion in net sales, respectively. The company's guidance also fell on the short end of estimates: Estée Lauder projected a 0%-3% growth in fiscal 2026 net sales, versus estimates from Visible Alpha of $14.78 billion, translating to a 3% increase from the $14.33 billion the company posted in fiscal 2025. Estée Lauder had struggled for years as it fell behind trends and was overly focused on Chinese consumers. The company sharpened its focus this year, boosting its stock price. The company's shares have gained 19% so far this year entering Wednesday. Read the original article on Investopedia Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store